Article Text
Abstract
Background/aim: Alpha-2α adrenergic receptor (α2-AR) agonists are thought to be neuroprotective, preventing retinal ganglion cell death independent of pressure reduction. Previous studies have identified α2-ARs in rat retina. The authors aimed to demonstrate the presence and localisation of α2-ARs in human and rat retina and on the rat retinal ganglion cell line, RGC-5.
Methods: Seven postmortem human and three postmortem rat eyes were paraformaldehyde fixed and frozen. RGC-5 cells were also paraformaldehyde fixed. The expression of α2A-ARs was determined by antibody immunofluorescence.
Results: α2A-AR expression was identified in the human retina, on ganglion cells, and cells in the inner and outer nuclear layers (INL, ONL). Differential α2A-AR staining patterns in the INL and ONL suggest a further restriction to as yet unidentified neuronal subclasses. The RGC-5 cell line also expressed α2A-ARs in undifferentiated cells and an increased expression upon fully differentiated cells.
Conclusion: α2-AR agonists in addition to their pressure lowering effects in the eye, may act directly upon retinal neurons, including retinal ganglion cells. The presence of α2-ARs on the RGC-5 cell line allows future investigation of these possible direct effects using in vitro glaucoma model systems.
- α2-AR, alpha-2 adrenergic receptor
- CRALBP, cellular retinaldehyde binding protein
- GCL, ganglion cell layer
- INL, inner nuclear layer
- ONL, outer nuclear layer
- PBS, phosphate buffered saline
- human ganglion cells
- alpha-2 receptors
- α2-AR, alpha-2 adrenergic receptor
- CRALBP, cellular retinaldehyde binding protein
- GCL, ganglion cell layer
- INL, inner nuclear layer
- ONL, outer nuclear layer
- PBS, phosphate buffered saline
- human ganglion cells
- alpha-2 receptors
Statistics from Altmetric.com
Footnotes
-
Competing interests: The authors have no competing or financial interests.
-
Ethics approval: University of New South Wales, Human Research Ethics Committee Approval 03225; University of New South Wales, Animal Care and Ethics Committee Approval 1997/101.